Treatment of CNS disorders using CNS target modulators
US7355042B2 · kind B2 · utility
35Cited by
59References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 23, 2004 |
| Grant date | Apr 8, 2008 |
| Priority date | — |
| Expiry date | May 17, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is directed to compositions and methods useful for treating Central Nervous System (CNS) disorders. Furthermore, the invention provides compositions and methods of treating sleep disorders. More specifically, the invention is directed to the compositions and use of derivatized, histamine antagonists for the treatment of sleep disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.